17-42543235-T-C
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PP3_Strong
The NM_000263.4(NAGLU):c.1229T>C(p.Phe410Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000681 in 1,614,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F410Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_000263.4 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 3BInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Myriad Women’s Health
- Charcot-Marie-Tooth disease axonal type 2VInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAGLU | NM_000263.4 | c.1229T>C | p.Phe410Ser | missense_variant | Exon 6 of 6 | ENST00000225927.7 | NP_000254.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAGLU | ENST00000225927.7 | c.1229T>C | p.Phe410Ser | missense_variant | Exon 6 of 6 | 1 | NM_000263.4 | ENSP00000225927.1 | ||
NAGLU | ENST00000591587.1 | c.*198T>C | 3_prime_UTR_variant | Exon 4 of 4 | 5 | ENSP00000467836.1 | ||||
NAGLU | ENST00000592454.1 | c.*72T>C | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000468665.1 | ||||
ENSG00000266929 | ENST00000585572.1 | n.379+4480T>C | intron_variant | Intron 3 of 4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251366 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727236 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: NAGLU c.1229T>C (p.Phe410Ser) results in a non-conservative amino acid change located in the Alpha-N-acetylglucosaminidase, tim-barrel domain (IPR024733) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251366 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1229T>C has been reported in the literature in at least one individual affected with Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome B) (Weber_1999). The report does not provide unequivocal conclusions about association of the variant with Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome B). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Mucopolysaccharidosis, MPS-III-B Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V Uncertain:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 410 of the NAGLU protein (p.Phe410Ser). This variant is present in population databases (rs574688121, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of mucopolysaccharidosis type IIIB (PMID: 10094189). ClinVar contains an entry for this variant (Variation ID: 556379). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NAGLU protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at